Azacitidine in Treating Patients With Myelofibrosis

Summary

RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of abnormal cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well azacitidine works in treating patients with myelofibrosis.

Timeline

Start

2006-08

Primary completion

2008-03

Completion

2009-04

Outcome

Outcome not reported

Stopped (Enrollment): “Due to lack of accrual and trial has demonstrated too little clinical benefit”

Drugs

Indications